Effects of Zolpidem CR® in Sleep and Heart Recovery in Cardiac Intensive Care Unit Patients
Status:
Unknown status
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
A double blind, randomized, placebo-controlled study will be conducted in cardiac ICU
patients who had been diagnosed with acute coronary syndrome, using a sleep promoting drug
(zolpidem controlled release).
The study hypothesis is that sleeping better can improve the heart recovery in patients with
a diagnosis of acute coronary syndrome.
Phase:
Phase 4
Details
Lead Sponsor:
Associação Fundo de Incentivo à Pesquisa
Collaborator:
Conselho Nacional de Desenvolvimento Científico e Tecnológico